BROMBIN, CHIARA
 Distribuzione geografica
Continente #
EU - Europa 19
NA - Nord America 7
AF - Africa 2
Totale 28
Nazione #
IT - Italia 17
US - Stati Uniti d'America 7
CZ - Repubblica Ceca 1
FR - Francia 1
MA - Marocco 1
ZA - Sudafrica 1
Totale 28
Città #
Milan 15
Portland 3
Bergamo 1
Boca Raton 1
Columbus 1
Pietermaritzburg 1
Tangier 1
Totale 23
Nome #
Ten Year Results of Extensive Nodal Radiotherapy and Moderately Hypofractionated Simultaneous Integrated Boost in Unfavorable Intermediate-, High-, and Very High-Risk Prostate Cancer, file 7239aa4a-23b4-4fc0-931d-0304c80d7c62 10
Genotoxic effects of base and prime editing in human hematopoietic stem cells, file 875b53f3-c96f-4a41-bc79-8beab1e66d68 4
Urokinase Receptor Promotes Skin Tumor Formation by Preventing Epithelial Cell Activation of Notch1, file e0c35a4b-d9e7-5883-e053-d805fe0ac580 4
Characterizing emotional response induced by affective stimuli using facial expression data, file e0c35a4c-9bf0-5883-e053-d805fe0ac580 4
Putative risk factors in devel- opmental dyslexia: a case-control study of Italian children, file e0c35a4b-dd01-5883-e053-d805fe0ac580 2
Analysis of healthcare workers' mental health during the COVID-19 pandemic: Evidence from a Three-Wave Longitudinal Study, file 014c2618-ec31-478b-8b4f-b0cc670ad946 1
Lentiviral vector gene therapy protects XCGD mice from acute Staphylococcus aureus pneumonia and inflammatory response, file e0c35a4b-d96a-5883-e053-d805fe0ac580 1
B-cell development and functions and therapeutic options in adenosine deaminase-deficient patients, file e0c35a4b-ed4a-5883-e053-d805fe0ac580 1
B-cell development and functions and therapeutic options in adenosine deaminase-deficient patients, file e0c35a4b-f274-5883-e053-d805fe0ac580 1
Totale 28
Categoria #
all - tutte 118
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 0 0 0 0 0 4 0 0 0 0 0 0
2022/202311 0 0 0 0 0 0 2 8 0 0 1 0
2023/20244 0 0 0 0 2 0 0 0 1 0 1 0
Totale 28